Michael B Hoffman
CIK 1290208 · Chairman and CEO · last filed 2026-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ONTX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ONE LAFAYETTE PLACE
GREENWICH, FL 06831
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TDACW | Chairman and CEO | — | $1.55 | — | $0 | 1 | 2026-05-29 |
| ANVS | Director | 3,514,458 | $0.96 | $3.38M | $4.46M | 21 | 2026-05-21 |
| Traws Pharma, Inc. (ONTXW) Delisted | Director | 564 | $0.07 | $38 | -$95.3K | 7 | 2020-08-31 |
| Traws Pharma, Inc. (ONTX.W) Delisted | Director | 982,549 | — | — | $0 | 1 | 2016-08-10 |
| ONTX | Director | 2,016 | $8.00 | $16.1K | $17.27M | 11 | 2016-05-20 |
Recent Filings · Page 3 of 5
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-08-31 | Traws Pharma, Inc. (ONTXW) Delisted | Sell (S) | −184,368 | -$50.1K | EDGAR |
| 2020-07-10 | Traws Pharma, Inc. (ONTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-06 | ANVS | Grant (A) | — | $0 | EDGAR |
| 2020-02-05 | ANVS | Mixed | +1,385,889 | $468.2K | EDGAR |
| 2019-07-29 | Traws Pharma, Inc. (ONTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-08-29 | Traws Pharma, Inc. (ONTXW) Delisted | Sell (S) | −99,999 | -$45.2K | EDGAR |
| 2018-07-30 | Traws Pharma, Inc. (ONTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-01 | Traws Pharma, Inc. (ONTXW) Delisted | Buy (P) | +2,211,765 | $0 | EDGAR |
| 2017-06-13 | Traws Pharma, Inc. (ONTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-08-10 | Traws Pharma, Inc. (ONTX.W) Delisted | Exer (X) | +528,845 | $2.17M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.